189 related articles for article (PubMed ID: 16224242)
21. Amelioration of Dalton's lymphoma-induced angiogenesis by melatonin.
Kumari R; Rawat K; Kumari A; Shrivastava A
Tumour Biol; 2017 Jun; 39(6):1010428317705758. PubMed ID: 28618962
[TBL] [Abstract][Full Text] [Related]
22. B-cell non-Hodgkin lymphoma: importance of angiogenesis and antiangiogenic therapy.
Jiang L; Li N
Angiogenesis; 2020 Nov; 23(4):515-529. PubMed ID: 32451774
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications.
Ellis LM; Takahashi Y; Liu W; Shaheen RM
Oncologist; 2000; 5 Suppl 1():11-5. PubMed ID: 10804085
[TBL] [Abstract][Full Text] [Related]
24. Angiogenesis in endocrine tumors.
Turner HE; Harris AL; Melmed S; Wass JA
Endocr Rev; 2003 Oct; 24(5):600-32. PubMed ID: 14570746
[TBL] [Abstract][Full Text] [Related]
25. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor as a target for anticancer therapy.
Ferrara N
Oncologist; 2004; 9 Suppl 1():2-10. PubMed ID: 15178810
[TBL] [Abstract][Full Text] [Related]
27. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML
Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568
[TBL] [Abstract][Full Text] [Related]
28. Angiogenesis: prognostic and therapeutic implications in gynecologic and breast malignancies.
Sauer G; Deissler H
Curr Opin Obstet Gynecol; 2003 Feb; 15(1):45-9. PubMed ID: 12544501
[TBL] [Abstract][Full Text] [Related]
29. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
30. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
31. Antiangiogenic cancer therapy.
Cao Y
Semin Cancer Biol; 2004 Apr; 14(2):139-45. PubMed ID: 15018898
[TBL] [Abstract][Full Text] [Related]
32. Increased vascularization predicts favorable outcome in follicular lymphoma.
Koster A; van Krieken JH; Mackenzie MA; Schraders M; Borm GF; van der Laak JA; Leenders W; Hebeda K; Raemaekers JM
Clin Cancer Res; 2005 Jan; 11(1):154-61. PubMed ID: 15671540
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor inhibitors in colon cancer.
Díaz-Rubio E
Adv Exp Med Biol; 2006; 587():251-75. PubMed ID: 17163170
[TBL] [Abstract][Full Text] [Related]
34. Antiangiogenic therapy in leukemia.
Thomas DA; Giles FJ; Cortes J; Albitar M; Kantarjian HM
Acta Haematol; 2001; 106(4):190-207. PubMed ID: 11815717
[TBL] [Abstract][Full Text] [Related]
35. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
Ferrara N
Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
[TBL] [Abstract][Full Text] [Related]
36. Angiogenesis in colorectal cancer: prognostic and therapeutic implications.
Giatromanolaki A; Sivridis E; Koukourakis MI
Am J Clin Oncol; 2006 Aug; 29(4):408-17. PubMed ID: 16891872
[TBL] [Abstract][Full Text] [Related]
37. III. Angiogenesis: complexity of tumor vasculature and microenvironment.
Furuya M; Yonemitsu Y; Aoki I
Curr Pharm Des; 2009; 15(16):1854-67. PubMed ID: 19519428
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis and antiangiogenic therapy in hematologic malignancies.
Dong X; Han ZC; Yang R
Crit Rev Oncol Hematol; 2007 May; 62(2):105-18. PubMed ID: 17188504
[TBL] [Abstract][Full Text] [Related]
39. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature.
Korpanty G; Carbon JG; Grayburn PA; Fleming JB; Brekken RA
Clin Cancer Res; 2007 Jan; 13(1):323-30. PubMed ID: 17200371
[TBL] [Abstract][Full Text] [Related]
40. Novel anti-angiogenic therapies for malignant gliomas.
Norden AD; Drappatz J; Wen PY
Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
